Zobrazeno 1 - 10
of 219
pro vyhledávání: '"LD Fisher"'
Mortality hazard functions as related to neutropenia at different times after marrow transplantation
Publikováno v:
Blood. 88:4058-4062
We characterized the relationship between severe neutropenia and risk of death in 2,276 patients after marrow transplantation to define objective and clinically relevant criteria that could be used to judge the timing and potential value of intervent
Autor:
Joel D. Meyers, LD Fisher, George B. McDonald, W. G. Meyer, David Myerson, Raleigh A. Bowden, Howard M. Shulman, George E. Sale, H. G. Schoch, Robert C. Hackman, F. Rossetti, D. L. Brawner
Publikováno v:
Clinical Infectious Diseases. 20:801-811
To determine the prevalence of fungal liver infection at autopsy in marrow transplant recipients, we reviewed autopsy results for the period 1980-1989. Cases were compared to randomly chosen autopsied controls without fungal infection. Fungal liver i
Publikováno v:
Controlled Clinical Trials. 15:450-462
We discuss the design and analysis of a proposed phase I/II clinical trial in bone marrow transplantation whereby dose modifications that decrease the risk of one complication increase the risk of another. Trials of this type are carried out to deter
Autor:
William I. Bensinger, John A. Hansen, Kristine Doney, Buckner Cd, Eileen Bryant, Raleigh A. Bowden, LD Fisher, H. J. Deeg, Thomas Ed, Reginald A. Clift
Publikováno v:
Blood. 84:2036-2043
A prospective randomized study was conducted comparing two conditioning regimens for the treatment of patients with chronic myeloid leukemia in chronic phase by marrow transplantation from HLA identical siblings. Sixty-nine patients received 60 mg/kg
Autor:
K Kawahara, R To, LD Fisher, K Mullally, A D Miller, FR Appelbaum, D Stewart, Theodore C. Graham, S Goehle, Friedrich Schuening
Publikováno v:
Blood. 78:2568-2576
Amphotropic helper-free retrovirus vectors containing the bacterial neomycin phosphotransferase gene (neo) and the human adenosine deaminase gene (adenosine aminohydrolase, EC 3.5.4.4; ADA) were used to transduce canine marrow cells. In one approach,
Autor:
John A. Hansen, Gary Schoch, Frederick R. Appelbaum, Paul J. Martin, George B. McDonald, Rainer Storb, LD Fisher, Vera Byers
Publikováno v:
Blood. 77:1821-1828
We have reviewed results of secondary therapy in 427 patients with acute graft-versus-host disease (GVHD) who did not have a durable satisfactory response after primary treatment. At the beginning of secondary treatment, 320 patients (75%) had rash,
Publikováno v:
American Journal of Clinical Pathology. 95:201-206
In situ hybridization for the Y chromosome (Y-ISH) was used to identify residual host cells in the peripheral blood of 51 recipients of sex-mismatched allogeneic marrow not depleted of T cells following conditioning with high-dose cyclophosphamide an
Autor:
FR Appelbaum, Patrick G. Beatty, LD Fisher, Kristine Doney, Buckner Cd, Finn Bo Petersen, Claudio Anasetti, Scott I. Bearman, William I. Bensinger, Reginald A. Clift
Publikováno v:
Blood. 76:1867-1871
A randomized trial of 12.0 Gy versus 15.75 Gy of total body irradiation (TBI) was performed in patients with acute myeloid leukemia undergoing allogeneic marrow transplantation while in first complete remission. All patients received 120 mg/kg cyclop
Autor:
Keith M. Sullivan, Jean E. Sanders, Mark M. Schubert, George E. Sale, LD Fisher, C. Beckham, Thomas H. Morton, TP Jr Loughran, Howard M. Shulman, Robert P. Witherspoon
Publikováno v:
Blood. 76:228-234
We prospectively evaluated 169 patients with a number of screening studies performed between 71 to 121 days after allogeneic marrow transplantation to detect the development of chronic graft-versus-host disease (GVHD). Group 1 patients (n = 78) were
Publikováno v:
Blood. 75:1888-1894
Epidemiologic and clinical characteristics of cytomegalovirus (CMV) infection and disease were analyzed retrospectively in 159 autologous marrow transplant recipients. The probability of CMV infection by day 100 after transplant was 22.5% in patients